ZURICH, Nov 7 (Reuters) - Swiss drugmaker Novartis AG (NOVN.VX: Quote, Profile, Research) said on Tuesday its Prexige painkiller had been approved for use in the European Union for patients with osteoarthritis.
ZURICH, Nov 7 (Reuters) - Swiss drugmaker Novartis AG (NOVN.VX: Quote, Profile, Research) said on Tuesday its Prexige painkiller had been approved for use in the European Union for patients with osteoarthritis.
